Additional early-stage research and drug discovery news in brief, from: Athira Pharma, Chroma Medicine, Cognition Therapeutics, Geovax Labs, Longhorn Vaccines and Diagnostics LLC, Omega Therapeutics.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Astrazeneca, Atreca, Genetex, Graphite, Inhalon, Lenz, Lilly, Point.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Astrazeneca, Atara, Ikena, Immutep, Janssen, Kiromic, Oncolytics, PDS, Pharmabcine, Recce, Senhwa, SFA, Trishula, Vaxcyte.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Advancell, Aim, Allgenesis, Alterity, Amgen, Arthrosi, Astrazeneca, Bioxcel, Durect, Gilead, HCW, Immatics, Janssen, Lumos, Morphogenesis, Replimune, Takeda.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Adverum, Alkeus, Apellis, Astellas, Astrazeneca, Bayer, Belite, Bloomsbury, Boehringer, Cassava, Celldex, Equillium, Faron, Fluoguide, Gannex, Idorsia, Immutep, Inflarx, Innovent, Iveric, Karyopharm, Kodiak, Maat, Mannkind, Moleculin, Moonlake, Neurosense, Nido, Qilu, Regenxbio, Soleno, Sellas, Sunstone, Tonix, Toragen, Vera, Verastem.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Amgen, DBV, Hibio, Merck & Co., Novartis, Novavax, Ocular.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Abcellera, Bayer, Blue Water, Globestar, Jaguar, J&J, Locanabio, Kura, Mirati, Prelude, Protagonist, Quadri, Rani, Sangamo, Siren, Smi, Theriva, Tonix.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Antibe, Ashvattha, Cardiol, Clearside, Curocell, Curevac, Cymabay, Dare, Evaxion, Innovative Cellular, Kazia, Merck & Co., Monopar, Silence, Soterios, Springworks, Tonix.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Allyx, Aptose, Aqilion, Coya, Deciphera, Geovax, GSK, Junshi, Leo, Novartis, Novelmed, Reviva, University of Oxford, Volastra, Vyne.